Edwards Lifesciences Corporation
EW | NYSE
$92.01
$0.00 (0.00%)
Nov 2, 2026, 9:30 AM ET · Market open
Market Data
Market Cap $53.03B
Enterprise Value $49.49B
Beta 0.86
Average Volume 3.92M
Shares Outstanding (Diluted) 577.6M
Shares Change YoY -1.75%
Institutional Ownership 90.75%
Exchange NYSE
ISIN US28176E1082
Price Performance
Price Change 1M 6.6%
Price Change 3M 6.9%
Price Change 6M 9.6%
Price Change YTD 7.9%
Price Change 1Y 11.6%
Price Change 3Y 44.4%
Price Change 5Y -23.2%
1M CAGR (ann.) 4.3%
1Y CAGR (ann.) 11.3%
5Y CAGR (ann.) -4.6%
All-Time CAGR 12.0%
Valuation
PE Ratio 52.88
Forward PE 27.39
PEG Ratio -0.70
Forward PEG 3.40
PS Ratio 8.14
Forward PS 7.10
PB Ratio 4.99
P/FCF Ratio 36.99
P/Adj. FCF Ratio 41.90
P/OCF Ratio 30.88
EV/Sales 7.60
EV/EBIT 34.92
EV/EBITDA 32.13
EV/FCF 34.52
Earnings Yield 1.9%
FCF Yield 2.7%
Adj. FCF Yield 2.4%
Financial Health
Net Cash $3.65B
Total Debt $704.4M
Cash & Short-Term Investments $4.25B
Total Assets $13.87B
Current Ratio 4.52
Quick Ratio 3.77
Debt / Equity Ratio 0.07
Debt / EBITDA 0.46
Debt / FCF 0.49
OCF / Debt 2.44
Interest Coverage 0.00
Altman Z-Score 12.89
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 78.0%
Operating Profit Margin 28.1%
EBITDA Margin 24.3%
Net Profit Margin 15.4%
FCF Margin 22.0%
Adj. FCF Margin 19.4%
SBC / Revenue 2.6%
SBC Impact (per share) -11.7%
Returns
Return on Assets 7.3%
Return on Equity 9.7%
Return on Invested Capital 10.2%
Return on Capital Employed 14.8%
Return on Tangible Assets 9.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.3%
Revenue CAGR 5Y 5.8%
Revenue CAGR 10Y 9.0%
EPS CAGR 3Y -8.3%
EPS CAGR 5Y -5.7%
EPS CAGR 10Y 8.1%
FCF CAGR 3Y 28.1%
FCF CAGR 5Y 6.4%
FCF CAGR 10Y 12.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 34.1%
Revenue Growth Next 3Y 11.4%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.74
EPS Growth Est (next Q) 9.8%
Revenue Est (next Q) $1.68B
Revenue Growth Est (next Q) 7.9%
Fair Value Estimates
Graham Number $26.99
Graham Upside -70.7%
Lynch Fair Value $8.70
Lynch Upside -90.5%
Price Target $103.88
Price Target Upside 12.9%
Cash Flow
Operating Cash Flow $1.72B
Free Cash Flow $1.43B
Adj. Free Cash Flow $1.27B
FCF Per Share $2.49
OCF Per Share $2.98
OCF/S Ratio 26.4%
Income Statement
Revenue $6.51B
Gross Profit $5.08B
Operating Income $1.83B
EBITDA $1.54B
Net Income $1B
EPS (Diluted) $1.74
Revenue / Employee $407.02K
Profit / Employee $62.81K
Employees 16,000
Add to Watchlist
Select watchlists to add or remove EW